Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Fbxo9 | Rat | (1->4)-beta-D-glucan | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FBXO9 mRNA | CTD | PMID:36331819 | Fbxo9 | Rat | 1,2-dichloroethane | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of FBXO9 mRNA | CTD | PMID:28960355 | Fbxo9 | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of FBXO9 mRNA | CTD | PMID:22206623 | Fbxo9 | Rat | 1,2-dimethylhydrazine | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBXO9 mRNA | CTD | PMID:22206623 | Fbxo9 | Rat | 1,3-dinitrobenzene | decreases expression | EXP | | 6480464 | 3-dinitrobenzene results in decreased expression of FBXO9 mRNA | CTD | PMID:21983209 | Fbxo9 | Rat | 1-chloro-2,4-dinitrobenzene | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Dinitrochlorobenzene results in decreased expression of FBXO9 mRNA | CTD | PMID:17374397 | Fbxo9 | Rat | 1-naphthyl isothiocyanate | decreases expression | EXP | | 6480464 | 1-Naphthylisothiocyanate results in decreased expression of FBXO9 mRNA | CTD | PMID:25380136 | Fbxo9 | Rat | 17alpha-ethynylestradiol | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of FBXO9 mRNA | CTD | PMID:17942748 | Fbxo9 | Rat | 17alpha-ethynylestradiol | increases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Ethinyl Estradiol results in increased expression of FBXO9 mRNA | CTD | PMID:17942748 | Fbxo9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [Tetrachlorodibenzodioxin co-treated with AHR gene mutant form] results in decreased expression of FBXO9 mRNA; [Tetrachlorodibenzodioxin more ... | CTD | PMID:17942748|PMID:19465110 | Fbxo9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of FBXO9 mRNA | CTD | PMID:33387578 | Fbxo9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of FBXO9 mRNA | CTD | PMID:21724226 | Fbxo9 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of FBXO9 mRNA | CTD | PMID:21570461 | Fbxo9 | Rat | 2-hydroxypropanoic acid | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of FBXO9 mRNA | CTD | PMID:30851411 | Fbxo9 | Rat | 3,4-methylenedioxymethamphetamine | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | N-Methyl-3,4-methylenedioxyamphetamine results in decreased expression of FBXO9 mRNA | CTD | PMID:26251327 | Fbxo9 | Rat | 4,4'-sulfonyldiphenol | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | bisphenol S results in decreased expression of FBXO9 mRNA | CTD | PMID:39298647 | Fbxo9 | Rat | 4-(ethoxymethylene)-2-phenyloxazol-5-one | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Oxazolone results in decreased expression of FBXO9 mRNA | CTD | PMID:17374397 | Fbxo9 | Rat | aflatoxin B1 | increases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Aflatoxin B1 results in increased expression of FBXO9 mRNA | CTD | PMID:19770486 | Fbxo9 | Rat | all-trans-retinoic acid | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of FBXO9 mRNA | CTD | PMID:21934132|PMID:23724009 | Fbxo9 | Rat | antirheumatic drug | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of FBXO9 mRNA | CTD | PMID:24449571 | Fbxo9 | Rat | aristolochic acid A | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of FBXO9 mRNA | CTD | PMID:33212167 | Fbxo9 | Rat | benzo[a]pyrene | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of FBXO9 mRNA | CTD | PMID:22228805 | Fbxo9 | Rat | bis(2-ethylhexyl) phthalate | increases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in increased expression of FBXO9 mRNA | CTD | PMID:21318169 | Fbxo9 | Rat | bisphenol A | increases methylation | ISO | FBXO9 (Homo sapiens) | 6480464 | bisphenol A results in increased methylation of FBXO9 gene | CTD | PMID:22576693 | Fbxo9 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of FBXO9 mRNA | CTD | PMID:30816183|PMID:32528016 | Fbxo9 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of FBXO9 mRNA | CTD | PMID:25181051|PMID:34947998 | Fbxo9 | Rat | bisphenol A | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of FBXO9 mRNA | CTD | PMID:22576693 | Fbxo9 | Rat | bisphenol F | increases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | bisphenol F results in increased expression of FBXO9 mRNA | CTD | PMID:38685157 | Fbxo9 | Rat | Butylbenzyl phthalate | increases methylation | ISO | Fbxo9 (Mus musculus) | 6480464 | butylbenzyl phthalate results in increased methylation of FBXO9 intron | CTD | PMID:28392331 | Fbxo9 | Rat | cadmium atom | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO9 more ... | CTD | PMID:37236586 | Fbxo9 | Rat | cadmium dichloride | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Cadmium Chloride results in decreased expression of FBXO9 mRNA | CTD | PMID:38568856 | Fbxo9 | Rat | cadmium dichloride | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of FBXO9 more ... | CTD | PMID:37236586 | Fbxo9 | Rat | CGP 52608 | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to FBXO9 gene] | CTD | PMID:28238834 | Fbxo9 | Rat | chlorpyrifos | increases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Chlorpyrifos results in increased expression of FBXO9 mRNA | CTD | PMID:29156651 | Fbxo9 | Rat | chlorpyrifos | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Chlorpyrifos results in decreased expression of FBXO9 mRNA | CTD | PMID:34289071 | Fbxo9 | Rat | choline | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... | CTD | PMID:20938992 | Fbxo9 | Rat | cisplatin | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in increased expression of FBXO9 mRNA] | CTD | PMID:21858171 | Fbxo9 | Rat | clofibric acid | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FBXO9 mRNA | CTD | PMID:17602206 | Fbxo9 | Rat | cobalt dichloride | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | cobaltous chloride results in increased expression of FBXO9 mRNA | CTD | PMID:19376846 | Fbxo9 | Rat | copper(II) sulfate | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of FBXO9 mRNA | CTD | PMID:19549813 | Fbxo9 | Rat | crocidolite asbestos | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Asbestos, Crocidolite results in decreased expression of FBXO9 mRNA | CTD | PMID:25351596 | Fbxo9 | Rat | cyclosporin A | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of FBXO9 mRNA | CTD | PMID:25562108 | Fbxo9 | Rat | dibutyl phthalate | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Dibutyl Phthalate results in decreased expression of FBXO9 mRNA | CTD | PMID:17361019 | Fbxo9 | Rat | dioxygen | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FBXO9 mRNA | CTD | PMID:30529165 | Fbxo9 | Rat | dorsomorphin | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Fbxo9 | Rat | entinostat | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Fbxo9 | Rat | entinostat | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | entinostat results in decreased expression of FBXO9 mRNA | CTD | PMID:26272509 | Fbxo9 | Rat | ethyl methanesulfonate | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Ethyl Methanesulfonate results in increased expression of FBXO9 mRNA | CTD | PMID:23649840 | Fbxo9 | Rat | eugenol | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Eugenol results in decreased expression of FBXO9 mRNA | CTD | PMID:17374397 | Fbxo9 | Rat | fenamidone | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | fenamidone results in decreased expression of FBXO9 mRNA | CTD | PMID:27029645 | Fbxo9 | Rat | fenofibrate | increases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Fenofibrate results in increased expression of FBXO9 mRNA | CTD | PMID:21318169 | Fbxo9 | Rat | flutamide | decreases expression | EXP | | 6480464 | Flutamide results in decreased expression of FBXO9 mRNA | CTD | PMID:24793618 | Fbxo9 | Rat | folic acid | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [1,2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of FBXO9 mRNA; [Methionine deficiency co-treated more ... | CTD | PMID:20938992|PMID:22206623 | Fbxo9 | Rat | formaldehyde | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Formaldehyde results in decreased expression of FBXO9 mRNA | CTD | PMID:20655997 | Fbxo9 | Rat | formaldehyde | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Formaldehyde results in increased expression of FBXO9 mRNA | CTD | PMID:23649840 | Fbxo9 | Rat | gentamycin | decreases expression | EXP | | 6480464 | Gentamicins results in decreased expression of FBXO9 mRNA | CTD | PMID:22061828 | Fbxo9 | Rat | hydrogen peroxide | affects expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of FBXO9 mRNA | CTD | PMID:20044591 | Fbxo9 | Rat | isoprenaline | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Isoproterenol results in decreased expression of FBXO9 mRNA | CTD | PMID:21335049 | Fbxo9 | Rat | isotretinoin | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Isotretinoin results in decreased expression of FBXO9 mRNA | CTD | PMID:20436886 | Fbxo9 | Rat | L-methionine | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression more ... | CTD | PMID:20938992 | Fbxo9 | Rat | lead diacetate | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | lead acetate results in decreased expression of FBXO9 mRNA | CTD | PMID:38568856 | Fbxo9 | Rat | leflunomide | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | leflunomide results in decreased expression of FBXO9 mRNA | CTD | PMID:28988120 | Fbxo9 | Rat | mercury dibromide | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | mercuric bromide results in decreased expression of FBXO9 mRNA | CTD | PMID:26272509 | Fbxo9 | Rat | mercury dibromide | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Fbxo9 | Rat | methapyrilene | decreases expression | EXP | | 6480464 | Methapyrilene results in decreased expression of FBXO9 mRNA | CTD | PMID:30467583 | Fbxo9 | Rat | methylmercury chloride | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | methylmercuric chloride results in decreased expression of FBXO9 mRNA | CTD | PMID:28001369 | Fbxo9 | Rat | Muraglitazar | increases expression | EXP | | 6480464 | muraglitazar results in increased expression of FBXO9 mRNA | CTD | PMID:21515302 | Fbxo9 | Rat | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FBXO9 mRNA | CTD | PMID:17602206 | Fbxo9 | Rat | N-nitrosodimethylamine | decreases expression | EXP | | 6480464 | Dimethylnitrosamine results in decreased expression of FBXO9 mRNA | CTD | PMID:25380136 | Fbxo9 | Rat | nickel sulfate | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of FBXO9 mRNA | CTD | PMID:18651567 | Fbxo9 | Rat | p-chloromercuribenzoic acid | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of FBXO9 mRNA | CTD | PMID:26272509 | Fbxo9 | Rat | p-chloromercuribenzoic acid | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Fbxo9 | Rat | panobinostat | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Fbxo9 | Rat | paracetamol | affects expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Acetaminophen affects the expression of FBXO9 mRNA | CTD | PMID:17562736 | Fbxo9 | Rat | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of FBXO9 mRNA | CTD | PMID:33387578 | Fbxo9 | Rat | paracetamol | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of FBXO9 mRNA | CTD | PMID:21420995 | Fbxo9 | Rat | perfluorooctane-1-sulfonic acid | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of FBXO9 mRNA | CTD | PMID:36331819 | Fbxo9 | Rat | phenobarbital | affects expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Phenobarbital affects the expression of FBXO9 mRNA | CTD | PMID:19159669 | Fbxo9 | Rat | phenylmercury acetate | affects expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Phenylmercuric Acetate affects the expression of FBXO9 mRNA | CTD | PMID:26272509 | Fbxo9 | Rat | phenylmercury acetate | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] affects the expression more ... | CTD | PMID:27188386 | Fbxo9 | Rat | pirinixic acid | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | pirinixic acid results in decreased expression of FBXO9 mRNA | CTD | PMID:18445702 | Fbxo9 | Rat | piroxicam | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | Cisplatin inhibits the reaction [Piroxicam results in increased expression of FBXO9 mRNA] | CTD | PMID:21858171 | Fbxo9 | Rat | piroxicam | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Piroxicam results in increased expression of FBXO9 mRNA | CTD | PMID:21858171 | Fbxo9 | Rat | rac-lactic acid | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Lactic Acid results in increased expression of FBXO9 mRNA | CTD | PMID:30851411 | Fbxo9 | Rat | resveratrol | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | [Plant Extracts co-treated with Resveratrol] results in increased expression of FBXO9 mRNA | CTD | PMID:23557933 | Fbxo9 | Rat | rotenone | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Rotenone results in decreased expression of FBXO9 mRNA | CTD | PMID:29955902 | Fbxo9 | Rat | SB 431542 | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression more ... | CTD | PMID:27188386 | Fbxo9 | Rat | silicon dioxide | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Silicon Dioxide results in decreased expression of FBXO9 mRNA | CTD | PMID:19073995 | Fbxo9 | Rat | silicon dioxide | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased expression of FBXO9 mRNA | CTD | PMID:22300531|PMID:25351596 | Fbxo9 | Rat | sodium arsenite | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of FBXO9 mRNA | CTD | PMID:38568856 | Fbxo9 | Rat | sunitinib | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Sunitinib results in increased expression of FBXO9 mRNA | CTD | PMID:31533062 | Fbxo9 | Rat | Tesaglitazar | increases expression | EXP | | 6480464 | tesaglitazar results in increased expression of FBXO9 mRNA | CTD | PMID:21515302 | Fbxo9 | Rat | thimerosal | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Thimerosal results in increased expression of FBXO9 mRNA | CTD | PMID:27188386 | Fbxo9 | Rat | thioacetamide | decreases expression | EXP | | 6480464 | Thioacetamide results in decreased expression of FBXO9 mRNA | CTD | PMID:34492290 | Fbxo9 | Rat | thiram | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Thiram results in decreased expression of FBXO9 mRNA | CTD | PMID:38568856 | Fbxo9 | Rat | titanium dioxide | increases methylation | ISO | Fbxo9 (Mus musculus) | 6480464 | titanium dioxide results in increased methylation of FBXO9 gene | CTD | PMID:35295148 | Fbxo9 | Rat | trichostatin A | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of FBXO9 mRNA | CTD | PMID:24935251 | Fbxo9 | Rat | trichostatin A | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | trichostatin A results in increased expression of FBXO9 mRNA | CTD | PMID:24935251 | Fbxo9 | Rat | triptonide | decreases expression | ISO | Fbxo9 (Mus musculus) | 6480464 | triptonide results in decreased expression of FBXO9 mRNA | CTD | PMID:33045310 | Fbxo9 | Rat | trovafloxacin | multiple interactions | ISO | Fbxo9 (Mus musculus) | 6480464 | [trovafloxacin co-treated with lipopolysaccharide, E coli O55-B5] results in decreased expression of FBXO9 mRNA | CTD | PMID:18930950 | Fbxo9 | Rat | valproic acid | decreases methylation | ISO | FBXO9 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of FBXO9 gene | CTD | PMID:29154799 | Fbxo9 | Rat | valproic acid | affects splicing | EXP | | 6480464 | Valproic Acid affects the splicing of FBXO9 mRNA | CTD | PMID:29427782 | Fbxo9 | Rat | valproic acid | multiple interactions | ISO | FBXO9 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased more ... | CTD | PMID:27188386 | Fbxo9 | Rat | valproic acid | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of FBXO9 mRNA | CTD | PMID:23179753|PMID:24383497|PMID:26272509|PMID:29154799 | Fbxo9 | Rat | valproic acid | affects expression | ISO | Fbxo9 (Mus musculus) | 6480464 | Valproic Acid affects the expression of FBXO9 mRNA | CTD | PMID:17292431 | Fbxo9 | Rat | valproic acid | increases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of FBXO9 mRNA | CTD | PMID:19101580|PMID:23179753 | Fbxo9 | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of FBXO9 mRNA | CTD | PMID:19015723 | Fbxo9 | Rat | vincristine | decreases expression | ISO | FBXO9 (Homo sapiens) | 6480464 | Vincristine results in decreased expression of FBXO9 mRNA | CTD | PMID:23649840 | |






















